Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice

Journal of Immunology

Volumn 165, Issue 8, 2000, Pages 4685-4696

  Noorchashm, H ^a   Moore, D J ^a   Noto, L E ^a   Noorchashm, N ^a   Reed, A J ^a   Reed, A L ^a   Song, H K ^a   Mozaffari, R ^a   Jevnikar, A M ^a   Barker, C F ^a   Naji, A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; IA ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL DEATH; CELL DIVISION; CONTROLLED STUDY; DIABETES MELLITUS; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0034667787     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.8.4685     Document Type: Article

References (52)

1. The NOD mouse model of type I diabetes: As good as it gets?
2. The NOD mouse
3. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
4. Genetic control of autoimmune diabetes in the NOD mouse
5. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities
6. Genetic control of diabetes progression
7. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity
8. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
9. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
10. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
11. The Fas death factor
12. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity
13. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B
14. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice
15. Enhanced and accelerated lympho-proliferation in Fas-null mice
16. Fatal interactions: Fas-induced apoptosis of mature T cells
17. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupusprone mice
18. + T cell population bearing a distinctive β-chain in MRL lpr/lpr mice suggests a role for the fas protein in peripheral T cell selection
19. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo
20. Cutting edge: Apoptosis of superantigen-activated T cells occurs preferentially after a discrete number of cell divisions in vivo
21. Hypogammaglobulinaemia occurs in Fas-deficient MRL-lpr mice following deletion of MHC class II molecules
22. Determination of lymphocyte division by flow cytometry
23. Following the fate of individual T cells throughout activation and clonal expansion: Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response
24. Helper T cell differentiation is controlled by the cell cycle
25. + T cell precursor frequency
26. Cutting edge: Alloimmune responses against major and minor histocompatibility antigens: Distinct division kinetics and requirement for CD28 costimulation
27. Monoclonal antibodies to murine CD3 ε define distinct epitopes, one of which may interact with CD4 during T cell activation
28. A cell culture model for T lymphocyte clonal anergy
29. + cells from old mice
30. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response
31. Principles of viral pathogenesis
32. Differential patterns of production of granulocyte macrophage colony stimulating factor, IL-2, IL-3 and IL-4 by cultured islets of Langerhans from non-obese diabetic and non-diabetic strains of mice
33. +-like thymocytes in the NOD mouse
34. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
35. Extreme Th1 bias of invariant Vα24JαQ T cells in type I diabetes
36. Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells
37. Breaking self-tolerance in nonobese diabetic mice
38. Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism
39. Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21 ras activation
40. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice: Evidence for thymic T cell anergy that correlates with the onset of insulitis
41. Splenic macrophages from the NOD mouse are defective in the ability to present antigen
42. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: Defective regulation of cytokine receptors and protein kinase C
43. Autoimmune diabetes results from genetic defects manifest by antigen presenting cells
44. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice
45. B lymphocytes are crucial antigen presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice
46. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: Analysis of a new 'speed congenic' stock of NOD Ig μ null mice
47. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in non-obese diabetic mice
48. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice
49. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet β cells of nonobese diabetic mice
50. The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice
51. TGF-β1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype
52. Local expression of TNF-α in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens